Dyed but not Dead

Ochsner Journal

Volumn 12, Issue 2, 2012, Pages 135-140

  Haque, Shireen H ^a,b   Nossaman, Bobby D ^a  

^a OCHSNER CLINIC FOUNDATION   (United States)

^b Southeast Anesthesiology Consultants   (United States)

Author keywords

Anaphylaxis; Cancer; Isosulfan blue; Methemoglobinemia; Pulse oximetry; Vital dyes

Indexed keywords

DOXAZOSIN; GLYCERYL TRINITRATE; ISOSULFAN BLUE; LEVOTHYROXINE; METOPROLOL; NORADRENALIN; NORMETADRENALIN; RABEPRAZOLE;

ADRENAL TUMOR; AGED; BLOOD GAS ANALYSIS; CANCER INVASION; CANCER LOCALIZATION; CASE REPORT; CLINICAL ASSESSMENT; DISEASE ASSOCIATION; FEMALE; HEADACHE; HEART PALPITATION; HUMAN; HUMAN TISSUE; HYPERTENSION; HYPOTHYROIDISM; HYPOXIA; MEDICAL HISTORY; PALLOR; PHEOCHROMOCYTOMA; POSITRON EMISSION TOMOGRAPHY; PREOPERATIVE EVALUATION; PULSE OXIMETRY; REHYDRATION; REVIEW; RISK ASSESSMENT; SENTINEL LYMPH NODE BIOPSY; SKIN DISCOLORATION; SQUAMOUS CELL CARCINOMA; SWEATING; THYROID NODULE; URTICARIA; VULVA CARCINOMA; VULVECTOMY;

EID: 84862736102     PISSN: 15245012     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (51)

1. Echt ML, Finan MA, Hoffman MS, Kline RC, Roberts WS, Fiorica JV. Detection of sentinel lymph nodes with lymphazurin in cervical, uterine, and vulvar malignancies. South Med J. 1999 Feb;92(2):204-208.
2. O'Boyle JD, Coleman RL, Bernstein SG, Lifshitz S, Muller CY, Miller DS. Intraoperative lymphatic mapping in cervix cancer patients undergoing radical hysterectomy: A pilot study. Gynecol Oncol. 2000 Nov;79(2):238-243.
3. Plante M, Renaud MC, Roy M. Sentinel node evaluation in gynecologic cancer. Oncology (Williston Park). 2004 Jan;18(1): 75-87; discussion 88-90, 95-96.
4. Levenback C, Burke TW, Gershenson DM, Morris M, Malpica A, Ross MI. Intraoperative lymphatic mapping for vulvar cancer. Obstet Gynecol. 1994 Aug;84(2):163-167.
5. Hirsch JI, Tisnado J, Cho SR, Beachley MC. Use of isosulfan blue for identification of lymphatic vessels: experimental and clinical evaluation. AJR Am J Roentgenol. 1982 Dec;139(6):1061-1064.
6. Laurie SA, Khan DA, Gruchalla RS, Peters G. Anaphylaxis to isosulfan blue. Ann Allergy Asthma Immunol. 2002 Jan;88(1): 64-66.
7. Cimmino VM, Brown AC, Szocik JF, et al. Allergic reactions to isosulfan blue during sentinel node biopsy-a common event. Surgery. 2001 Sep;130(3):439-442.
8. Leong SP, Donegan E, Heffernon W, Dean S, Katz JA. Adverse reactions to isosulfan blue during selective sentinel lymph node dissection in melanoma. Ann Surg Oncol. 2000 Jun;7(5):361-366.
9. Longnecker SM, Guzzardo MM, Van Voris LP. Life-threatening anaphylaxis following subcutaneous administration of isosulfan blue 1%. Clin Pharm. 1985 Mar-Apr;4(2):219-221.
10. Thevarajah S, Huston TL, Simmons RM. A comparison of the adverse reactions associated with isosulfan blue versus methylene blue dye in sentinel lymph node biopsy for breast cancer. Am J Surg. 2005 Feb;189(2):236-239.
11. Kaufman G, Guth AA, Pachter HL, Roses DF. A cautionary tale: anaphylaxis to isosulfan blue dye after 12 years and 3339 cases of lymphatic mapping. Am Surg. 2008 Feb;74(2):152-155.
12. Komenaka IK, Bauer VP, Schnabel FR, et al. Allergic reactions to isosulfan blue in sentinel lymph node mapping. Breast J. 2005 Jan-Feb;11(1):70-72.
13. Montgomery LL, Thorne AC, Van Zee KJ, et al. Isosulfan blue dye reactions during sentinel lymph node mapping for breast cancer. Anesth Analg. 2002 Aug;95(2):385-388.
14. Raut CP, Daley MD, Hunt KK, et al. Anaphylactoid reactions to isosulfan blue dye during breast cancer lymphatic mapping in patients given preoperative prophylaxis. J Clin Oncol. 2004 Feb 1; 22(3):567-568.
15. Raut CP, Hunt KK, Akins JS, et al. Incidence of anaphylactoid reactions to isosulfan blue dye during breast carcinoma lymphatic mapping in patients treated with preoperative prophylaxis: results of a surgical prospective clinical practice protocol. Cancer. 2005 Aug 15;104(4):692-699.
16. Golshan M, Nakhlis F. Can methylene blue only be used in sentinel lymph node biopsy for breast cancer? Breast J. 2006 Sep-Oct;12(5):428-430.
17. Scherer K, Studer W, Figueiredo V, Bircher AJ. Anaphylaxis to isosulfan blue and cross-reactivity to patent blue V: case report and review of the nomenclature of vital blue dyes. Ann Allergy Asthma Immunol. 2006 Mar;96(3):497-500.
18. Sandhu S, Farag E, Argalious M. Anaphylaxis to isosulfan blue dye during sentinel lymph node biopsy. J Clin Anesth. 2005 Dec; 17(8):633-635.
19. Momeni R, Ariyan S. Pulse oximetry declines due to intradermal isosulfan blue dye: a controlled prospective study. Ann Surg Oncol. 2004 Apr;11(4):434-437.
20. Daley MD, Norman PH, Leak JA, et al. Adverse events associated with the intraoperative injection of isosulfan blue. J Clin Anesth. 2004 Aug;16(5):332-341.
21. Hoskin RW, Granger R. Intraoperative decrease in pulse oximeter readings following injection of isosulfan blue. Can J Anaesth. 2001 Jan;48(1):38-40.
22. Burgoyne LL, Jay DW, Bikhazi GB, De Armendi AJ. Isosulfan blue causes factitious methemoglobinemia in an infant. Paediatr Anaesth. 2005 Dec;15(12):1116-1119.
23. Wear KD, Karsif K, Turner J. Staining of endotracheal tube with isosulfan blue dye after sentinel node mapping: a case report. Breast J. 2003 Jan-Feb;9(1):47-48.
24. Piñero A, Illana J, García-Palenciano C, et al. Effect on oximetry of dyes used for sentinel lymph node biopsy. Arch Surg. 2004 Nov; 139(11):1204-1207.
25. Steele SR, Martin MJ, Mullenix PS, Olsen SB, Andersen CA. Intraoperative use of isosulfan blue in the treatment of persistent lymphatic leaks. Am J Surg. 2003 Jul;186(1):9-12.
26. Hill AD, Tran KN, Akhurst T, et al. Lessons learned from 500 cases of lymphatic mapping for breast cancer. Ann Surg. 1999 Apr;229(4):528-535.
27. Kieckbusch H, Coldewey SM, Hollenhorst J, Haeseler G, Hillemanns P, Hertel H. Patent blue sentinel node mapping in cervical cancer patients may lead to decreased pulse oximeter readings and positive methaemoglobin results. Eur J Anaesthesiol. 2008 May;25(5):365-368. Epub 2008 Feb 13.
28. Chia YY, Liu K, Kao PF, Sun GC, Wang KY. Prolonged interference of patent blue on pulse oximetry readings. Acta Anaesthesiol Sin. 2001 Mar;39(1):27-32.
29. Wisely NA, Zeiton Z. Use of isosulfan blue in breast surgery interferes with pulse oximetry. Anaesthesia. 2005 Jun;60(6): 625-626.
30. Heinle E, Burdumy T, Recabaren J. Factitious oxygen desaturation after isosulfan blue injection. Am Surg. 2003 Oct;69(10): 899-901.
31. Vokach-Brodsky L, Jeffrey SS, Lemmens HJ, Brock-Utne JG. Isosulfan blue affects pulse oximetry. Anesthesiology. 2000 Oct; 93(4):1002-1003.
32. Coleman RL, Whitten CW, O'Boyle J, Sidhu B. Unexplained decrease in measured oxygen saturation by pulse oximetry following injection of Lymphazurin 1% (isosulfan blue) during a lymphatic mapping procedure. J Surg Oncol. 1999 Feb;70(2): 126-129.
33. Rizzi RR, Thomas K, Pilnik S. Factious desaturation due to isosulfan dye injection. Anesthesiology. 2000 Oct;93(4): 1146-1147.
34. El-Tamer M, Komenaka IK, Curry S, Troxel AB, Ditkoff BA, Schnabel FR. Pulse oximeter changes with sentinel lymph node biopsy in breast cancer. Arch Surg. 2003 Nov;138(11): 1257-1260.
35. Mateo D, Suescun MC, Cahisa M, Ruiz P, García M, Miranda L. [Decreasing oxygen saturation detected by pulse oximetry after the administration of isosulfan blue]. Rev Esp Anestesiol Reanim. 2002 Feb;49(2):114-115. Spanish.
36. Ralston AC, Webb RK, Runciman WB. Potential errors in pulse oximetry. III: effects of interferences, dyes, dyshaemoglobins and other pigments. Anaesthesia. 1991 Apr;46(4):291-295.
37. Schnapp LM, Cohen NH. Pulse oximetry. Uses and abuses. Chest. 1990 Nov;98(5):1244-1250.
38. Guay J. Methemoglobinemia related to local anesthetics: a summary of 242 episodes. Anesth Analg. 2009 Mar;108(3): 837-845.
39. Young B. Intraoperative detection of methemoglobinemia in a patient given benzocaine spray to relieve discomfort from a nasogastric tube: a case report. AANA J. 2008 Apr;76(2):99-102.
40. Kwok S, Fischer JL, Rogers JD. Benzocaine and lidocaine induced methemoglobinemia after bronchoscopy: a case report. J Med Case Reports. 2008 Jan 23;2:16.
41. Wurdeman RL, Mohiuddin SM, Holmberg MJ, Shalaby A. Benzocaine-induced methemoglobinemia during an outpatient procedure. Pharmacotherapy. 2000 Jun;20(6):735-738.
42. Mack E. Focus on diagnosis: co-oximetry. Pediatr Rev. 2007 Feb; 28(2):73-74.
43. Haymond S, Cariappa R, Eby CS, Scott MG. Laboratory assessment of oxygenation in methemoglobinemia. Clin Chem. 2005 Feb;51(2):434-444. Epub 2004 Oct 28.
44. Mathews PJ Jr. Co-oximetry. Respir Care Clin N Am. 1995 Sep; 1(1):47-68.
45. García Carmona T, Domíneguez De Villota E, Mosquera Gonzalez M, Muedra Lopez A, Ruíz De Andrés S, Estada Girauta J. [P 50: Comparison between the values based on calculated saturations from oxygen contents (Van Slyke) and on optically measured saturations (Co-Oximetry)]. Rev Clin Esp. 1975 Jul 31;138(2): 149-153. Spanish.
46. Soni M, Saha S, Korant A, et al. A prospective trial comparing 1% lymphazurin vs 1% methylene blue in sentinel lymph node mapping of gastrointestinal tumors. Ann Surg Oncol. 2009 Aug; 16(8):2224-2230. Epub 2009 May 30.
47. Albo D, Wayne JD, Hunt KK, et al. Anaphylactic reactions to isosulfan blue dye during sentinel lymph node biopsy for breast cancer. Am J Surg. 2001 Oct;182(4):393-398.
48. Lyew MA, Gamblin TC, Ayoub M. Systemic anaphylaxis associated with intramammary isosulfan blue injection used for sentinel node detection under general anesthesia. Anesthesiology. 2000 Oct;93(4):1145-1146.
49. Sprung J, Tully MJ, Ziser A. Anaphylactic reactions to isosulfan blue dye during sentinel node lymphadenectomy for breast cancer. Anesth Analg. 2003 Apr;96(4):1051-1053.
50. Schwartz LB, Metcalfe DD, Miller JS, Earl H, Sullivan T. Tryptase levels as an indicator of mast-cell activation in systemic anaphylaxis and mastocytosis. N Engl J Med. 1987 Jun 25; 316(26):1622-1626.
51. Schwartz LB. Tryptase, a mediator of human mast cells. J Allergy Clin Immunol. 1990 Oct;86(4 Pt 2):594-598.